spacer
home > pmps > Summer 2008
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Summer 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS.
   
Text
PDF
bullet
Manufacturing
X-Ray systems are becoming increasingly valued by the pharmaceutical industry as an indispensable means of non-destructive testing; Martin Allen of Shaw Inspection Systems takes a closer look  
view
download pdf
The automated CheckWeighing system for dry powder inhalers supports the quality assurance process, outlines James Aitken of Aitken Scientific  
view
download pdf
Elisabethann Wright of Hogan & Hartson Brussels consider the European Commision’s attempts to strengthen the legal framework for regulating medical devices in Europe  
view
download pdf
Tom Roche at FM Global assesses how a single incident in one country can have a disastrous impact on the entire global economy  
view
download pdf
bullet
Drug Delivery 
Frances L DeGrazio at West Pharmaceutical Services, Inc, outlines the procedures involved and the importance of thorough testing in the leachables and extractables field  
view
download pdf
Stephen Grant at ANSYS discusses how computational fluid dynamics (CFD) enable a fast and cost-effective evaluation of new drug delivery systems and formulations  
view
download pdf
Douglas Custato at Helvoet Pharma outlines the options pharma companies will be presented with when choosing the ideal elastomeric closure  
view
download pdf
Andy Wallace at Comark Ltd encourages investment in wireless monitoring systems – a key tool for those looking to expand into emerging markets  
view
download pdf
bullet
Formulations, Ingredients and Excipients
Many active pharmaceutical ingredients are unstable and subject to degradation. The role of excipients is therefore being viewed as progressively more important. Nigel A Langley and Karen H Chen at Croda Inc (USA) explain how.  
view
download pdf
Dr Robert Hardy of Aesica explains to PMPS that exceptional service and a well-balanced business model is key in providing contract services to the outsourcing industry  
view
download pdf
bullet
IT and Logistics
Guido Moosmann of Schreiner MediPharm explores the latest innovative technologies for clinical trial supply management  
view
download pdf
bullet
PACKING, PACKAGING & ANTI-COUNTERFEITING
John Haworth at Ditone Labels looks at how the pharma packaging industry has responded to the needs of the blind community  
view
download pdf
Nicole Golomb at 3S Simons Security Systems GmbH takes us through the various options available to avoid the counterfeit risk  
view
download pdf
Low and microdose powder filling in the pharmaceutical industry has traditionally been a challenging process. However, new developments are on the way, as Robin Davies of Isopak Ltd explains  
view
download pdf
bullet
COOL CHAIN
Robert Kayum at Kuehne + Nagel explores today’s climate for temperature-sensitive logistics, and the developments in solutions that can transform the role they play in the pharma industry  
view
download pdf
   
spacer
Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August, and November

News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Choosing the Right CMO for HPAPI Manufacturing

AMRI

Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem — which CMO should you pick when each is touting similar technical capabilities?
More info >>

Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement